Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
Pharma
Novo Nordisk rekindles heart failure hopes for semaglutide
After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for semaglutide are starting to get back on track.
Fraiser Kansteiner
Aug 30, 2024 11:48am
Lilly unveils diabetes prevention data for star drug tirzepatide
Aug 20, 2024 9:35am
Lilly lifts guidance by $3B after strong GLP-1 performance
Aug 8, 2024 11:18am
Genentech, ADA launch eye health equity program in D.C.
Aug 7, 2024 12:13pm
Novo scoops up 200 acres for a potential new production plant
Jul 23, 2024 10:35am
Insulet drops song using all the sounds of an Omnipod 5 pod swap
Jul 22, 2024 2:25pm
